Suivre
Meghan Collins
Meghan Collins
Adresse e-mail validée de austin.utexas.edu
Titre
Citée par
Citée par
Année
Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism
A Lodi, A Saha, X Lu, B Wang, E Sentandreu, M Collins, MG Kolonin, ...
NPJ precision oncology 1 (1), 18, 2017
852017
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
TA Yap, N Daver, M Mahendra, J Zhang, C Kamiya-Matsuoka, ...
Nature medicine 29 (1), 115-126, 2023
812023
Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD–Positive AML
ME Zavorka Thomas, X Lu, Z Talebi, JY Jeon, DR Buelow, AA Gibson, ...
Molecular cancer therapeutics 20 (11), 2207-2217, 2021
282021
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
N Baran, A Lodi, Y Dhungana, S Herbrich, M Collins, S Sweeney, ...
Nature communications 13 (1), 2801, 2022
272022
Novel strategy for untargeted chiral metabolomics using liquid chromatography-high resolution tandem mass spectrometry
R Pandey, M Collins, X Lu, SR Sweeney, J Chiou, A Lodi, S Tiziani
Analytical chemistry 93 (14), 5805-5814, 2021
222021
Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor‐B cell acute …
SR Sweeney, M Collins, R Pandey, J Chiou, A Lodi, S Tiziani
Molecular Carcinogenesis 59 (4), 399-411, 2020
222020
Predicting and quantifying antagonistic effects of natural compounds given with chemotherapeutic agents: Applications for high-throughput screening
GL Hackman, M Collins, X Lu, A Lodi, J DiGiovanni, S Tiziani
Cancers 12 (12), 3714, 2020
152020
The combined treatment with the FLT3-inhibitor AC220 and the complex I inhibitor IACS-010759 synergistically depletes Wt-and FLT3-mutated acute myeloid leukemia cells
X Lu, L Han, J Busquets, M Collins, A Lodi, JR Marszalek, M Konopleva, ...
Frontiers in Oncology 11, 686765, 2021
122021
The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy
SM Stanford, M Collins, MA Diaz, ZJ Holmes, P Gries, MR Bliss, A Lodi, ...
Journal of cellular physiology 236 (9), 6630-6642, 2021
82021
Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry
X Lu, GL Hackman, A Saha, AS Rathore, M Collins, C Friedman, SS Yi, ...
Iscience 25 (5), 2022
52022
Targeting Oxidative Phosphorylation with a Mitochondrial Complex I Inhibitor is limited by Mechanism-based Toxicity
M Konopleva, T Yap, N Daver, M Mahendra, J Zhang, ...
32022
Isolation of Synergistic Natural Products Targeting Metabolic Dysfunction in Pediatric Pre‐B Cell Acute Lymphoblastic Leukemia Using High‐Throughput Screening and Metabolomics
ME Collins, SR Sweeney, S Tiziani
The FASEB Journal 33 (S1), lb225-lb225, 2019
12019
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses
M Konopleva, C DiNardo, T Bhagat, N Baran, A Lodi, K Saxena, T Cai, ...
Research Square, 2023
2023
Lipophagy As a Mechanism of Resistance in T-ALL Following Energetic Crisis Induced By Oxphos/MCT1 Blockade: Strategies to Eradicate Residual Disease
N Baran, S Patel, CL Ramage, A Lodi, JE Ortiz, Y Dhungana, M Collins, ...
Blood 140 (Supplement 1), 8831-8832, 2022
2022
Accumulation of Intracellular L-Lactate and Irreversible Disruption of Mitochondrial Membrane Potential upon Dual Inhibition of Oxphos and Lactate Transporter MCT-1 Induce …
N Baran, S Patel, A Lodi, JE Ortiz, Y Dhungana, M Collins, A Skwarska, ...
Blood 138, 680, 2021
2021
Gilteritinib Inhibits Acute Myeloid Leukemia Growth via Reduction in Glutamine Uptake and Utilization
MZ Thomas, JY Jeon, S Shabana, D Buelow, A Gibson, J Anderson, ...
The FASEB Journal 34 (S1), 1-1, 2020
2020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–16